Who is sponsoring NCT04859049?

NCT04859049 is sponsored by Research Institute of Ophthalmology, Egypt.

What drugs are being tested in NCT04859049?

Interventions in NCT04859049: infromedial single injection, medial canthus injection.

What condition does NCT04859049 study?

NCT04859049 studies Pain Due to Certain Specified Procedures.

Is NCT04859049 still recruiting?

NCT04859049 is currently status unknown. Last updated 21 September 2022.

Last reviewed 2022-09-21 · How we verify

NCT04859049

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single Injection Infromedial Peribulbar Injection in Lacrimal Duct

Status unknown NA Last updated 21 September 2022

What this trial tests

NA trial testing infromedial single injection in Pain Due to Certain Specified Procedures in 50 participants. Status unknown.

Timeline

10 September 2021

Primary endpoint
1 November 2022

1 November 2022

Quick facts

Lead sponsor	Research Institute of Ophthalmology, Egypt
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	50
Start date	10 September 2021
Primary completion	1 November 2022
Estimated completion	1 November 2022
Sites	2 locations across Egypt

Drugs / interventions tested

infromedial single injection
medial canthus injection

Conditions studied

Pain Due to Certain Specified Procedures — all drugs for Pain Due to Certain Specified Procedures →

Sponsor

Research Institute of Ophthalmology, Egypt

Who can join

Adults 16 to 70, any sex, with Pain Due to Certain Specified Procedures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

infromedial injection of 3 ml local anesthetic drugs and assessing the pain during lacrimal duct intubation and probability of false tracking

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Research Institute of Ophthalmology, Egypt trials

Trials by the same sponsor.

NCT05539924 — Pregabalin Versus Gabapentin Opioid Sparing Effect in Discectomy · Phase 3 · unknown
NCT05728151 — Comparing General Anesthesia With Single Injection Peribulbar Block With 3 Different Drugs · NA · completed
NCT05069350 — Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI · EARLY_PHASE1 · completed
NCT04859062 — Lidocaine Gel 2% and Muscle Traction Pain During Squint Surgery in Pediatrics · NA · completed
NCT05031312 — Inferior Oblique Myectomy Versus Anterior and Nasal Transposition of Its Tendon for Treatment of Superior Oblique Muscle · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04859049 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Research Institute of Ophthalmology, Egypt
Last refreshed: 21 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04859049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing